BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28823752)

  • 21. HER2 testing of gastro-oesophageal adenocarcinoma: a commentary and guidance document from the Association of Clinical Pathologists Molecular Pathology and Diagnostics Committee.
    Wong NACS; Amary F; Butler R; Byers R; Gonzalez D; Haynes HR; Ilyas M; Salto-Tellez M; Taniere P
    J Clin Pathol; 2018 May; 71(5):388-394. PubMed ID: 29439009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human epidermal growth factor receptor 2 testing in gastric carcinoma: issues related to heterogeneity in biopsies and resections.
    Lee S; de Boer WB; Fermoyle S; Platten M; Kumarasinghe MP
    Histopathology; 2011 Nov; 59(5):832-40. PubMed ID: 22092394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathologic diagnostics of HER2 positivity in gastroesophageal adenocarcinoma.
    Koopman T; Louwen M; Hage M; Smits MM; Imholz AL
    Am J Clin Pathol; 2015 Feb; 143(2):257-64. PubMed ID: 25596252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HER2 status in gastric and gastroesophageal junction cancer assessed by local and central laboratories: Chinese results of the HER-EAGLE study.
    Huang D; Lu N; Fan Q; Sheng W; Bu H; Jin X; Li G; Liu Y; Li X; Sun W; Zhang H; Li X; Zhou Z; Yan M; Wang X; Sha W; Ji J; Cheng X; Zhou Z; Xu J; Du X
    PLoS One; 2013; 8(11):e80290. PubMed ID: 24244671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EGFR gene amplification is relatively common and associates with outcome in intestinal adenocarcinoma of the stomach, gastro-oesophageal junction and distal oesophagus.
    Birkman EM; Ålgars A; Lintunen M; Ristamäki R; Sundström J; Carpén O
    BMC Cancer; 2016 Jul; 16():406. PubMed ID: 27387915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor containing fragment number influences immunohistochemistry positive rate of HER2 in biopsy specimens of gastric cancer.
    Xu C; Liu Y; Ge X; Jiang D; Zhang Y; Ji Y; Hou J; Huang J; Su J; Zeng H; Qin J; Hou Y
    Diagn Pathol; 2017 May; 12(1):41. PubMed ID: 28549444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Five biopsy specimens from the proximal part of the tumor reliably determine HER2 protein expression status in gastric cancer.
    Tominaga N; Gotoda T; Hara M; Hale MD; Tsuchiya T; Matsubayashi J; Kono S; Kusano C; Itoi T; Fujimoto K; Moriyasu F; Grabsch HI
    Gastric Cancer; 2016 Apr; 19(2):553-560. PubMed ID: 25987463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ideal number of biopsy tumor fragments for predicting HER2 status in gastric carcinoma resection specimens.
    Ahn S; Ahn S; Van Vrancken M; Lee M; Ha SY; Lee H; Min BH; Lee JH; Kim JJ; Choi S; Jung SH; Choi MG; Lee JH; Sohn TS; Bae JM; Kim S; Kim KM
    Oncotarget; 2015 Nov; 6(35):38372-80. PubMed ID: 26460823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HER2 testing in gastric cancer diagnosis: insights on variables influencing HER2-positivity from a large, multicenter, observational study in Germany.
    Baretton G; Kreipe HH; Schirmacher P; Gaiser T; Hofheinz R; Berghäuser KH; Koch W; Künzel C; Morris S; Rüschoff J;
    Virchows Arch; 2019 May; 474(5):551-560. PubMed ID: 30826877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human epithelial growth factor receptor 2 (HER2) status in primary and metastatic esophagogastric junction adenocarcinomas.
    Fassan M; Ludwig K; Pizzi M; Castoro C; Guzzardo V; Balistreri M; Zaninotto G; Ruol A; Giacomelli L; Ancona E; Rugge M
    Hum Pathol; 2012 Aug; 43(8):1206-12. PubMed ID: 22217477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of HER2 by automated FISH and IHC in gastric carcinoma biopsies.
    Silva MR; Alarcão A; Ferreira T; d'Aguiar M; Ladeirinha A; Balseiro S; Carvalho L
    Int J Biol Markers; 2016 Feb; 31(1):e38-43. PubMed ID: 26349667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathological features and endoscopic findings of HER2-positive gastric cancer.
    Oono Y; Kuwata T; Takashima K; Yoda Y; Ikematsu H; Shitara K; Kinoshita T; Yano T
    Surg Endosc; 2018 Sep; 32(9):3964-3971. PubMed ID: 29500656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2).
    Feilchenfeldt J; Varga Z; Siano M; Grabsch HI; Held U; Schuknecht B; Trip A; Hamaguchi T; Gut P; Balague O; Khanfir K; Diebold J; Jochum W; Shoji H; Kushima R; Wagner D; Shimada Y; Cats A; Knuth A; Moch H; Aebi S; Hofer S
    Br J Cancer; 2015 Sep; 113(5):716-21. PubMed ID: 26313663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HER2 Status in Gastric and Gastroesophageal Junction Cancer: Results of the Large, Multinational HER-EAGLE Study.
    Kim WH; Gomez-Izquierdo L; Vilardell F; Chu KM; Soucy G; Dos Santos LV; Monges G; Viale G; Brito MJ; Osborne S; Noé J; Du X
    Appl Immunohistochem Mol Morphol; 2018 Apr; 26(4):239-245. PubMed ID: 27490762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HER2 testing in gastric cancer: a practical approach.
    Rüschoff J; Hanna W; Bilous M; Hofmann M; Osamura RY; Penault-Llorca F; van de Vijver M; Viale G
    Mod Pathol; 2012 May; 25(5):637-50. PubMed ID: 22222640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HER2 testing in gastric and gastroesophageal adenocarcinomas.
    Vakiani E
    Adv Anat Pathol; 2015 May; 22(3):194-201. PubMed ID: 25844677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A nCounter CNV Assay to Detect HER2 Amplification: A Correlation Study with Immunohistochemistry and In Situ Hybridization in Advanced Gastric Cancer.
    Ahn S; Hong M; Van Vrancken M; Lyou YJ; Kim ST; Park SH; Kang WK; Park YS; Jung SH; Woo M; Lee J; Kim KM
    Mol Diagn Ther; 2016 Aug; 20(4):375-83. PubMed ID: 27179810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significant intratumoral heterogeneity of human epidermal growth factor receptor 2 status in gastric cancer: A comparative study of immunohistochemistry, FISH, and dual-color in situ hybridization.
    Kanayama K; Imai H; Yoneda M; Hirokawa YS; Shiraishi T
    Cancer Sci; 2016 Apr; 107(4):536-42. PubMed ID: 26752196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early HER2 dysregulation in gastric and oesophageal carcinogenesis.
    Fassan M; Mastracci L; Grillo F; Zagonel V; Bruno S; Battaglia G; Pitto F; Nitti D; Celiento T; Zaninotto G; Fiocca R; Rugge M
    Histopathology; 2012 Nov; 61(5):769-76. PubMed ID: 22882541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validated clinico-pathologic nomogram in the prediction of HER2 status in gastro-oesophageal cancer.
    Fornaro L; Vivaldi C; Parnofiello A; Ugolini C; Aprile G; De Maglio G; Pecora I; Iacono D; Crivelli F; Catanese S; Cardellino GG; Lencioni M; Vasile E; Salani F; Clerico M; Calvetti L; Falcone A; Fasola G; Fontanini G; Montagnani F
    Br J Cancer; 2019 Mar; 120(5):522-526. PubMed ID: 30745584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.